Author: Khodaei, Forouzan; Ahsan, Anam; Chamanifard, Mostafa; Zamiri, Mohammad Javad; Ommati, Mohammad Mehdi
Title: Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor Cord-id: tt8k04zj Document date: 2020_8_8
ID: tt8k04zj
Snippet: The new coronavirus (COVIDâ€19) was first reported in Wuhan in China, on 31 December 2019. COVIDâ€19 is a new virus from the family of coronaviruses that can cause symptoms ranging from a simple cold to pneumonia. The virus is thought to bind to the angiotensinâ€converting enzyme 2, as a wellâ€known mechanism to enter the cell. It then transfers its DNA to the host in which the virus replicates the DNA. The viral infection leads to severe lack of oxygen, lung oxidative stress because of reac
Document: The new coronavirus (COVIDâ€19) was first reported in Wuhan in China, on 31 December 2019. COVIDâ€19 is a new virus from the family of coronaviruses that can cause symptoms ranging from a simple cold to pneumonia. The virus is thought to bind to the angiotensinâ€converting enzyme 2, as a wellâ€known mechanism to enter the cell. It then transfers its DNA to the host in which the virus replicates the DNA. The viral infection leads to severe lack of oxygen, lung oxidative stress because of reactive oxygen species generation, and overactivation of the immune system by activating immune mediators. The purpose of this review is to elaborate on the more precise mechanism(s) to manage the treatment of the disease. Regarding the mechanisms of the virus action, the suggested pharmacological and nutritional regimens have been described.
Search related documents:
Co phrase search for related documents- abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
- abdominal pain and low prevalence: 1, 2, 3, 4
- abdominal pain and lung damage: 1
- abdominal pain and lung fever: 1
- abdominal pain diarrhea and lopinavir ritonavir: 1, 2, 3
- abdominal pain diarrhea and low prevalence: 1
- abdominal pain diarrhea and lung damage: 1
- abdominal pain diarrhea and lung fever: 1
- abdominal pain diarrhea vomiting and lopinavir ritonavir: 1, 2
- abdominal pain diarrhea vomiting and low prevalence: 1
- abdominal pain diarrhea vomiting nausea and low prevalence: 1
- abnormal growth and activity overexpression: 1
- abnormal growth and low prevalence: 1
- ace inhibit and acute lung injury: 1
- ace inhibit and lopinavir ritonavir: 1
- ace inhibit and lung fever: 1
- activity overexpression and acute lung injury: 1
- acute lung injury and lopinavir ritonavir: 1, 2, 3, 4, 5
- acute lung injury and low prevalence: 1
Co phrase search for related documents, hyperlinks ordered by date